ICICI Prudential Nifty Pharma Index Fund

ICICI Prudential Mutual Fund · Index Funds (Equity) · Direct Growth · AMFI 150930 · ISIN INF109KC11M9
NAV₹21.971720 Nov 2026
3Y return+21.62%a year
5Y return—a year
Expense ratio0.51%₹177 Cr
Growth Score82.8★★★★★

Returns

1M3M6MYTD1Y3Y5Y7Y10YSince launch
Fund+10.79%+7.38%+14.44%+25.12%+25.25%+21.62%———+22.33%
NIFTY Pharma TRI+10.85%+7.49%+14.67%+25.66%+25.86%+22.31%+16.87%———
Category middle+8.41%+0.48%+6.20%+2.07%+1.17%+11.34%+8.84%+12.47%+13.25%—

Risk (36 months)

Volatility14.95%
Sharpe1.01
Sortino1.67
Beta1.00
Alpha-0.32%
Deepest fall-16.59%
1-year periods with a loss9%
5Y SIP XIRR—

Top holdings (31 Oct 2026)

Sun Pharmaceutical Industries Ltd.18.60%
Divi's Laboratories Ltd.12.28%
Laurus Labs Ltd.9.26%
Dr. Reddy's Laboratories Ltd.8.15%
Cipla Ltd.7.67%
Torrent Pharmaceuticals Ltd.6.71%
Lupin Ltd.4.83%
Aurobindo Pharma Ltd.4.59%
Glenmark Pharmaceuticals Ltd.3.42%
Zydus Lifesciences Ltd.3.05%
Alkem Laboratories Ltd.3.04%
Mankind Pharma Ltd.2.79%

Sectors

Pharmaceuticals & Biotechnology99.9%

Calculated by Growth Analyser from AMFI NAVs and the fund house's disclosed portfolio. Up to 1 year: total return; longer: CAGR. Research and education only; not investment advice. Mutual fund investments are subject to market risks; read all scheme-related documents carefully. Past performance does not indicate future returns.